Mon May 30, 2022 – 4:15 pm EDT
(LifeSiteNews) – New data suggests that AstraZeneca’s COVID-19 jab is associated with an increased risk of the degenerative nervous disorder Guillain-Barré syndrome (GBS), an autoimmune condition which can cause “devastating paralysis.”
Researchers at University College London’s (UCL) Queen Square Institute of Neurology identified the Oxford/AstraZeneca-designed COVID jab as correlative with a rise in cases of GBS between two and four weeks of receiving the shot, the Telegraph reported.
The research team, led by Professor Michael Lunn, said that the same effect had not been discovered in either Pfizer of Moderna’s mRNA-developed jabs, leading them to speculate that the “Trojan horse” delivery system utilized in the AstraZeneca jab could be the cause of GBS development.
“At the moment we don’t know why a vaccine may cause these very small rises in GBS. It may be that a non-specific immune activation in susceptible individuals occurs, but if that were the case similar risks might apply to all vaccine types,” Lunn told the Telegraph.
AstraZeneca developed its COVID shot using a weakened chimpanzee adenovirus to deliver the COVID spike protein into the body of recipients. While the UCL team suggested that
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
